Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«BAD

Below is an extended BAD publications listing. Click here to return to the gene page.

Gene Information from Publications

Publication Link Summary of findings
18006502 Raf-1 in beta-cells led to a striking loss of Bad phosphorylation at serine 112 and an increase in the protein levels of both Bad and Bax
17900801 AG490 enhances UCN-01-induced cytotoxicity in p53 defective cell lines by suppression of BAD phosphorylation and induction of BAX and PARP cleavage
17696989 reelin binds to apoE receptors activating the PI3 K/Akt pathway causing phosphorylation of BAD which protects cells from apoptosis
17499381 The presence of wild type PRV US3, but not of the point-mutated PRV US3, results in phosphorylation of the pro-apoptotic Bad protein in PRV-infected HEp-2 cells.
17670745 a novel role for BAD in cell cycle regulation dependent upon its phosphorylation state and independent of the BAD/BCL2 interaction and apoptosis.
17393317 Expression of p-BAD was increased in the colorectal cancer cells and may possibly alter the cell death regulation during colorectal tumorigenesis.
17696955 decreased expression of p-BAD in malignant gastric epithelial cells suggested loss of p-BAD expression may play a role in gastric tumorigenesis; data also suggest BAD mutation may not be a direct target of inactivation in gastric tumorigenesis
17404594 p53 can form a complex with dephosphorylated Bad thereby converting it to a pro-apoptotic player.
17287851 Akt/Bad pathway generates a progressive resistance to apoptosis, at a time HTLV-I genes expression is silenced.
17541305 Bcl-2 induces the expression of matrix metalloproteinases in renal cell tumors grown in the orthotopic sites, though no appreciable effects were observed in vitro.
17544220 Lysophosphatidic acid prevents apoptosis of Caco-2 colonic neoplasms via activation of mitogen-activated protein kinase and phosphorylation of BAD.
17438366 BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between BECN1 and BAX and Bcl-2.
11781193 expression in normal, hyperplastic and carcinomatous human prostate
11878929 results suggest that direct interaction of Bad with pro-survival members of the Bcl-2 family contributes to the progress of Sindbis virus-induced apoptosis
16728406 antiapoptotic signaling pathways activated by vasoactive intestinal polypeptide, epidermal growth factor, and phosphatidylinositol 3-kinase in prostate cancer cells converge on BAD
12965220 Mutation of BAD within the BH3 domain modulates its apoptotic function.
14767529 Bad is increased in quercetin-treated nasopharyngeal carcinoma cells
15767261 AR and IGF1 cooperate to prevent apoptosis by activating a specific PKC-p90(rsk)-dependent pathway, which leads to Bad and Bax inactivation.
12084714 BAD cleavage and apoptosis in tumor cells in response to raloxifene
15731037 degraded during Chlamydia trachomatis infection
15751984 A recombinant fusion protein linking human granulocyte-macrophage colony-stimulating factor to the N-terminus of the proapoptotic protein BAD delivers BAD into tumor cells, where it restores the apoptotic pathway.
12239175 role of PI3-kinase-dependent phosphorylation and altered transcription in cytokine-mediated neutrophil survival
15226424 constitutively active Rac1 is shown to stimulate the phosphorylation of Bad, thereby suppressing drug-induced caspase activation and apoptosis in human lymphoma cells; Rac1 activation leads to Bad phosphorylation specifically at serine-75
12657644 study suggests that the cleavage of 14-3-3 protein during apoptosis promotes cell death by releasing the associated Bad protein from the 14-3-3 protein and facilitates Bad translocation to the mitochondria and its interaction with Bcl-x(L)
15901741 BAD induces apoptosis upon detecting the coincidence of G2/M phase and growth factor deprivation
16603546 the interaction of BAD with membranes is tied to binding of 14-3-3 protein and activation and membrane translocation of Bcl-XL
17011751 Raf-1 and B-Raf promote protein kinase C theta interaction with BAD.
17446862 The functional and physical interaction between Bcl-X(L) and a BH3-like domain in BECN1 was studied.
16297499 Bcl-xL mRNA overexpression may suggest poor prognosis in NSCLC.
17110373 dissociation of Bad from Bcl-xL and an increase in the intracellular level of Bcl-xL are responsible for development of acquired TRAIL resistance
16148027 Bax, Bad, and Bim are upregulated, while Bcl-2 is downregulated in human neuroblastoma cells treated with propargylamine
16484005 There was no somatic mutation of BH3 domains of Bad, Bmf and Bcl-G genes in transitional cell carcinoma samples. The data presented here indicate that BH3 domain mutation of these genes is rare in TCCs and may not contribute to the pathogenesis of TCCs.
16785131 Cytogenetic investigation of a nodal diffuse large B cell lymphoma carrying an IGH-BCL2-fusion revealed a homogeneously staining region at chromosome 1p21-22.
16847055 EGF protects prostate cancer cells from apoptosis by inducing BAD phosphorylation via redundant signaling pathways
12087097 effects of paclitaxel on BAD phosphorylation in ovarian cancer cells
12954615 BAD is a substrate for pim-2 oncogene proto-oncogene
16767165 Phosphorylation of BAD or inhibition of its translocation to the mitochondria are critical survival pathways in LNCaP tumor cells.
16908594 Bad translocation to mitochondria plays a critical role in Tetrahydrocannabinol-induced apoptosis in Jurkat cells.
16978419 Mycobacterium leprae inhibits apoptosis in THP-1 cells by downregulation of Bad and Bak and upregulation of Mcl-1 gene expression.
17557568 data presented here indicate that BH3 domain mutation of the proapoptotic genes Bad, Bmf and Bcl-G is rare in laryngeal squamous cell carcinoma and may not contribute to the apoptosis-resistance mechanisms of laryngeal squamous cell carcinoma
15231831 mechanisms that regulate the conversion of BAD from an anti-death to a pro-death factor include alternative splicing that produces N-terminally truncated BAD(S)and conversion by caspases into a pro-death fragment that resembles the short splice variant
15849194 Pak1-dependent Raf-1 phosphorylation regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association
12754297 BAD-mediated sensitivity of prosstatic cancer cells to TRAIL depends on the phosphorylation status of BAD WT and tBAD.
17420275 GATA1 and GFI1B interplay to regulate bcl-X protein transcription.
11839683 Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation
15033904 Bad gene is occasionally mutated in colon cancer
16843435 doxorubicin-stimulated phosphorylation of Bad in cells expressing dominant negative p38 MAPK was impeded by the inhibition of PI3-kinase
16932738 AKT-induced BAD phosphorylation and its subsequent cytoplasmic sequestration by 14-3-3zeta is a major mechanism responsible for the postponement of UVB-induced apoptosis in human keratinocytes.
16949642 The high expression of bad in Hodgkin and Reed-Sternberg cells in most classical Hodgkin's lymphomas (HLs)indicates that this protein may play predominant role in the regulation of apoptosis in classical HLs.
16710454 Sequestration of BAD away from mitochondria provides C. trachomatis with mechanism to protect host cell from apoptosis via interaction of a C. trachomatis-encoded inclusion protein with host-cell phosphoserine-binding protein. (BAD protein)

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.